Adult Thyroid Courses
Overview
Most patients with differentiated thyroid cancer fall into low-risk
stages, where survival is >90%. Therefore, for these patients, initial
stratification for risk of structural disease recurrence should be the primary
determinant for therapeutic decision-making about surgery, radioiodine, and TSH
suppression.
After primary therapy, surveillance data from serum thyroglobulin testing and
ultrasound imaging can be used to guide long-term follow-up.
Thyroglobulin (Tg) measurement remains the cornerstone of modern management of differentiated thyroid cancer (DTC), with clinical decisions on treatment and follow-up based on the results of such measurements. However, Tg measurement is a highly complex process with many pitfalls and interferences, most notably from anti-thyroglobulin antibodies (TgAb).This session will review and discuss issues concerning analytical aspects of hsTg and TgAb measurement and issues related to the clinical consequ...